BioSpace News Archive

Policy

KemPharm’s KP484 for the Treatment of ADHD, An Investigational Prodrug of Methylphenidate, Allowed to Proceed to Clinical Studies

The company may proceed with its planned clinical investigation for the treatment of attention deficit hyperactivity disorder.

November 2, 2017
·
5 min read
Business

Cerveau Technologies and Sinotau Pharmaceutical Group Announce Sinotau’s Achievement of a Major Milestone in China Strategy

Sinotau Pharmaceuticals has announced today an agreement with HTA CO. LTD for launching a new β-amyloid imaging agent for Alzheimer’s disease in China.

November 2, 2017
·
2 min read
Pharm Country

Cancer Genetics is Among the First To Drive New FDA-Approved Testing Paradigm for Non-Small Cell Lung Cancer Patients by Offering Thermo Fisher Scientific’s Oncomine Dx Target Test

November 2, 2017
·
5 min read
Business

VBI Vaccines Strengthens Board of Directors With Appointment of Ran Nussbaum

“We are honored to have Ran join our Board of Directors,” said Jeff Baxter, VBI’s president and CEO.

November 2, 2017
·
5 min read
Business

Progenics Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Update

Third quarter revenue totaled $2.7 million, down from $53.9 million in the third quarter of 2016, reflecting RELISTOR royalty income of $2.6 million compared to $3.3 million in the corresponding period of 2016.

November 2, 2017
·
13 min read
Business

Evogene Financial Results for the Third Quarter of 2017 Earnings Announcement Schedule

On the day of the announcement, the Company’s management will host a conference call to discuss the results at 09:00 AM ET.

November 2, 2017
·
2 min read
Policy

Galapagos Moving Forward in CF Programs at NACFC 2017

Ten posters and four oral presentations reflect progress toward triple combination therapy.

November 2, 2017
·
5 min read
Deals

Allena Pharma Announces Pricing of Initial Public Offering

The company announced the pricing of its initial public offering of 5,333,333 shares of common stock at a public offering price of $14.00 per share.

November 2, 2017
·
2 min read
Business

iPharma Enters Into Licensing Agreement With Boehringer Ingelheim to Obtain Worldwide Rights to FAK Inhibitor Oncology Development Program

iPharma, Ltd. announced today that it has entered into an exclusive worldwide license agreement with Boehringer Ingelheim.

November 2, 2017
·
3 min read
Business

AveXis to Report Third Quarter 2017 Financial and Operating Results

Conference call and webcast will be on November 9 at 4:30 p.m. ET.

November 2, 2017
·
2 min read